MarketCapTrends
PHIO

Phio Pharmaceuticals Corp. (PHIO)

NASDAQ · Healthcare

Phio Pharmaceuticals Corp. annual/quarterly shareholder equity history from 2012 to 2020. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Phio Pharmaceuticals Corp. shareholder equity for the quarter ending December 31, 2020 were 13.0M, a 126.46% increase year-over-year.
  • Phio Pharmaceuticals Corp. shareholder equity for 2020 were 13.0M, a 126.46% increase from 2019.
  • Phio Pharmaceuticals Corp. shareholder equity for 2019 were 5.7M, a 57.67% decrease from 2018.
  • Phio Pharmaceuticals Corp. shareholder equity for 2018 were 13.6M, a 640.75% increase from 2017.
  • Phio Pharmaceuticals Corp. shareholder equity for 2017 were 1.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Phio Pharmaceuticals Corp. Annual Shareholder Equity (Millions of US $)
2020$13
2019$6
2018$14
2017$2
2016$11
2015$9
2013$5
2012$-6
Phio Pharmaceuticals Corp. Quarterly Shareholder Equity (Millions of US $)
2020-12-31$13
2019-12-31$6
2018-12-31$14
2017-12-31$2
2016-12-31$11
2015-12-31$9
2013-12-31$5
2012-12-31$-6

Phio Pharmaceuticals Corp. Shareholder Equity — FAQ

Phio Pharmaceuticals Corp. (PHIO) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PHIO's shareholder equity history?

The chart and table above show Phio Pharmaceuticals Corp.'s shareholder equity by year and by quarter, including the growth rate.